REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA

Neurology

Volumn 61, Issue 1, 2003, Pages 29-34

  Gilman, S ^a   Koeppe, R A ^a   Chervin, R D ^a   Consens, F B ^a   Little, R ^b   An, H ^b   Junck, L ^a   Heumann, M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 11; DIHYDROTETRABENAZINE; IODINE 123; IODOBENZOVESAMICOL; UNCLASSIFIED DRUG; VESAMICOL DERIVATIVE;

ADULT; AGED; ARTICLE; CELL DENSITY; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROMYOGRAM; FEMALE; HUMAN; LIGAND BINDING; MALE; MONOAMINERGIC SYSTEM; NERVE ENDING; PARASOMNIA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SHY DRAGER SYNDROME; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THALAMUS;

EID: 0038353570     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000073745.68744.94     Document Type: Article

References (48)

1. Rye DB. Contributions of the pedunculopontine region to normal and altered REM sleep. Sleep 1997;20:757-788.
2. Jouvet M, Delorme F. Locus coeruleus et sommeil paradoxal. CR Soc Biol 1965;159:895-899.
3. Hendricks JC, Morrison AR, Mann GL. Different behaviors during paradoxical sleep without atonia depend on the pontine lesion site. Brain Res 1982;239:81-105.
4. Schenck CH, Bundlie SR, Ettinger MG, Mahowald MW. Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 1986;9:293-308.
5. Plazzi G, Corsini R, Provini F, et al. REM sleep behavior disorders in multiple system atrophy. Neurology 1997;48:1094-1097.
6. Lantos PL, Papp MI. Cellular pathology of multiple system atrophy: a review. J Neurol Neurosurg Psychiatry 1994;57:129-133.
7. Spokes EG, Bannister R, Oppenheimer DR. Multiple system atrophy with autonomic failure: clinical, histological and neurochemical observations on four cases. J Neurol Sci 1979;43:59-82.
8. Gilman S, Frey KA, Koeppe RA, et al. Decreased striatal monoaminergic terminals in olivopontocerebellar atrophy and multiple system atrophy demonstrated with positron emission tomography. Ann Neurol 1996;40:885-892.
9. Gilman S, Koeppe RA, Junck L, et al. Decreased striatal monoaminergic terminals in multiple system atrophy detected with PET. Ann Neurol 1999;45:769-777.
10. Kim YJ, Ichise M, Ballinger JR, et al. Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP. Mov Disord 2002;17:303-312.
11. Benarroch EE, Schmeichel AM, Parisi JE. Depletion of cholinergic neurons of the medullary arcuate nucleus in multiple system atrophy. Auton Neurosci 2001;87:293-299.
12. Norbiato G, Bevilacqua M, Righini V, et al. Altered vosopressin response to metoclopramide in multiple system atrophy: evidence of a cholinergic deficit in the hypothalamus. Acta Neurol Scand 1992;85:299-303.
13. Steriade M, Paré D, Datta S, Oakson G, Dossi RC. Different cellular types in mesopontine cholinergic nuclei related to ponto-geniculooccipital waves. J Neurosci 1990;10:2560-2579.
14. Albin RL, Koeppe RA, Chervin RD, et al. Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology 2000;55:1410-1412.
15. Eisensehr I, Linke R, Noachtar S, Schwarz J, Gildehaus FJ, Tatsch K. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Comparison with Parkinson's disease and controls. Brain 2000;123:1155-1160.
16. Semba K, Reiner PB, Fibiger HC. Single cholinergic mesopontine tegmental neurons project to both the pontine reticular formation and the thalamus in the rat. Neuroscience 1990;3:643-654.
17. Losier BJ, Semba K. Dual projections of single cholinergic and aminergic brainstem neurons to the thalamus and basal forebrain in the rat. Brain Res 1993;604:41-52.
18. Gilman S, Koeppe RA, Chervin R, et al. A correlation between REM sleep behavior disorder and striatal monoaminergic innervation in multiple system atrophy. Mov Disord 2002;17:S166. Abstract.
19. Gilman S, Low PA, Quinn N, et al. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 1999;163:94-98.
20. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques, and scoring system for sleep stages of human subjects. Los Angeles: Brain Information Service/Brain Research Institute, 1968.
21. Lapierre O, Montplaisir J. Polysomnographic features of REM sleep behavior disorder: development of a scoring method. Neurology 1992;42:1371-1374.
22. Kunz D, Bes F. Melatonin as a therapy in REM sleep behavior disorder patients: an open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation. Mov Disord 1999;14:507-511.
23. Takeuchi N, Uchimura N, Hashizume Y, et al. Melatonin therapy for REM sleep behavior disorder. Psychiatr Clin Neurosci 2001;55:267-270.
24. Miyamoto M, Miyamoto T, Takekawa H, Kubo J, Hirata K. Parasomnia as an occasion for the diagnosis of Parkinson's disease. Psychiatr Clin Neurosci 2001;55:273-274.
25. Wetter TC, Trenkwalder C, Gershanik O, et al. Polysomnographic measures in Parkinson's disease: a comparison between patients with and without REM sleep disturbances. Wien Klin Wochenschr 2001;113:249-253.
26. Frey KA, Koeppe RA, Kilbourn MR, et al. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Ann Neurol 1996;40:873-884.
27. 11C]dihydrotetrabenazine (DTBZ) and PET. J Cereb Blood Flow Metab 1997;17:919-931.
28. 125I-labeled cholinergic nerve marker (-)-5-iodobenzovesamicol. Nucl Med Biol 1993;20:929-937.
29. Kuhl DE, Minoshima S, Fessler JA, et al. In vivo mapping ofcholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Ann Neurol 1996;40:399-410.
30. Kuhl DE, Koeppe RA, Fessler JA, et al. In vivo mapping of cholinergic neurons in the human brain using SPECT and IBVM. J Nucl Med 1994;35:405-410.
31. Rogers GA, Parsons SM, Anderson DC, et al. Synthesis, in vitro acetylcholine-storage-blocking activities, and biological properties of derivatives and analogues of trans-2-(4-phenyl-piperidino)cyclohexanol (vesamicol). J Med Chem 1989;32:1217-1230.
32. SAS. SAS/STAT user's guide version 6. 4th ed. Cary, NC: SAS Institute, 1990.
33. Olson EJ, Boeve BF, Silber MH. Rapid eye movement sleep behaviour disorder: demographic, clinical and laboratory findings in 93 cases. Brain 2000;123:331-339.
34. Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder. Neurology 1996;46:388-393.
35. Tan A, Salgado M, Fahn S. Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa. Mov Disord 1996;11:214-216.
36. Comella CL, Tanner C, Ristanovic R. Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations. Ann Neurol 1993;34:710-714.
37. Mahowald MW, Schenck CH. REM sleep parasomnias. In: Kryger MH, Roth T, Dement WC, eds. Principles and practice of sleep medicine. 3rd ed. Philadelphia: Saunders, 2000:724-741.
38. Tachibana N, Kimura K, Kitajima K, et al. REM sleep motor dysfunction in multiple system atrophy: with special emphasis on sleep talk as its early clinical manifestation. J Neurol Neurosurg Psychiatry 1997;63:678-681.
39. Clarke NA, Williams AJ, Kopelman MD. Rapid eye movement sleep behavior disorder, depression and cognitive impairment. Br J Psychiatry 2000;176:189-192.
40. Tison F, Wenning GK, Quinn NP. REM sleep behavior disorder as the presenting symptom of multiple system atrophy. J Neurol Neurosurg Psychiatry 1995;58:379-380.
41. Wright BA, Rosen Jr, Buysse DJ, et al. Shy-Drager syndrome presenting as a REM behavioral disorder. J Geriatr Psychiatry Neurol 1990;3:110-113.
42. Duda JE, Giasson BI, Gur TL, et al. Immunohistochemical and biochemical studies demonstrate a distinct profile of alpha-synuclein permutations in multiple system atrophy. J Neuropathol Exp Neurol 2000;59:830-841.
43. Farrer M, Maraganore DM, Lockhart P, et al. Alpha-synuclein gene haplotypes are associated with Parkinson's disease. Human Mol Genet 2001;10:1847-1851.
44. Boeve BF, Silber MH, Ferman TJ, et al. REM sleep behavior disorder and degenerative dementia: an association likely reflecting Lewy body disease. Neurology 1998;51:363-370.
45. Boeve BF, Silver MH, Ferman TJ, et al. Association of REM sleep behavior disorder and neurodegenerative disease may reflect an underlying synucleinopathy. Mov Disord 2001;16:622-630.
46. Garcia-Rill E. The pedunculopontine nucleus. Prog Neurobiol 1991;36:363-389.
47. Segawa M, Nomura Y, Hakamada S, et al. Polysomnography. Functional topographical examination of the basal ganglia. Brain Dev 1986;8:475-481.
48. Gagnon J, Bédard M, Fantini ML, et al. REM sleep behavior disorder and REM sleep without atonia in Parkinson's disease. Neurology 2002;59:585-589.